Clinical studies recruiting near Fullerton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0162 · Bristol-Myers Squibb · NCT07106762 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Providence Medical Foundation · Pfizer · NCT06758401 A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
Phase 1 · Providence Medical Foundation · TORL Biotherapeutics, LLC · NCT06005740 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · Providence Medical Foundation · Fate Therapeutics · NCT06308978 Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1 · Providence Saint Jude Medical Center · Amgen · NCT04221542 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Providence Medical Foundation · Pfizer · NCT07144280 Molecular Genetics Studies of Cancer Patients and Their Relatives
Phase N/A · Saint Jude Medical Center · City of Hope Medical Center · NCT04185935 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Providence Saint Jude Medical Center · Amgen · NCT07005128 CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery i
Phase 1/Phase 2 · Providence St. Jude Medical Center · TORL Biotherapeutics, LLC · NCT07322094 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Providence St. Jude Medical Center ( Site 0106) · Merck Sharp & Dohme LLC · NCT06623422 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site US085 · Incyte Corporation · NCT07522073 The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
Phase 4 · Marshall B. Ketchum University · Southern California College of Optometry at Marshall B. Ketc · NCT06655441 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Providence - St. Jude Medical Center /ID# 256520 · AbbVie · NCT06345339 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Providence Medical Foundation ( Site 0049) · Merck Sharp & Dohme LLC · NCT07133633 A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.
NA · Regenerative Solutions · McGuire Institute · NCT06914596 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 169 · Adverum Biotechnologies, Inc. · NCT07482176 Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Phase 3 · Southern California College of Optometry · Jaeb Center for Health Research · NCT06380517 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Neurology Center of North Orange County · Hoffmann-La Roche · NCT07174310 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Im
Phase 1/Phase 2 · Providence - St. Jude Medical Center /ID# 271414 · AbbVie · NCT06772623 A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
Phase 3 · Marshall B. Ketchum University · Jaeb Center for Health Research · NCT07095894 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Clinical Research Providence Medical Foundation · Daiichi Sankyo · NCT06203210 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · Providence Medical Foundation - Fullerton /ID# 274207 · AbbVie · NCT07023289 Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Phase 1/Phase 2 · Providence Medical Foundation · Stemline Therapeutics, Inc. · NCT05386108 Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degen
Phase 2 · Adverum site 169 · Adverum Biotechnologies, Inc. · NCT07630649 First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Phase 1 · Providence Medical Foundation · TORL Biotherapeutics, LLC · NCT05103683 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Providence Medical Foundation ( Site 0087) · Merck Sharp & Dohme LLC · NCT03486873 A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Providence Medical Foundation · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · Retina Consultants of Orange County · 4D Molecular Therapeutics · NCT07064759 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET
Phase 3 · Fullerton Neurology and Headache Center · Bristol-Myers Squibb · NCT06976203 Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Phase 1 · Research Site · AstraZeneca · NCT07201558

Look up another city

Look up another condition